Literature DB >> 14734640

Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries.

Yinong Wang1, William R Burns, Paul C Y Tang, Tai Yi, Jeffrey S Schechner, Hans-Guenter Zerwes, William C Sessa, Marc I Lorber, Jordan S Pober, George Tellides.   

Abstract

Vascular remodeling (change in vessel diameter) rather than intimal hyperplasia is the most important predictor of luminal loss in immune-mediated arterial injury, yet little is known about its mechanisms. Here, we show that outward vascular remodeling and intimal thickening, two manifestations of arteriosclerosis with opposing effects on luminal size, result from immune effector mechanisms that are T-cell dependent and interferon (IFN)-gamma mediated. In our in vivo model of human coronary artery injury by allogeneic peripheral blood mononuclear cells, both processes occur concurrently and are characterized by T-cell infiltrates with a predominantly IFN-gamma-producing cytokine profile. Neutralization of IFN-gamma inhibits the arterial and intimal expansion, whereas administration of IFN-gamma enhances these effects. The nonredundant role of IFN-gamma in T-cell-dependent remodeling of human coronary arteries demonstrated here presents a new therapeutic target for preservation of vessel lumen in arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734640     DOI: 10.1096/fj.03-0840fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  29 in total

1.  VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling.

Authors:  Jiasheng Zhang; Teresa Silva; Timur Yarovinsky; Thomas D Manes; Sina Tavakoli; Lei Nie; George Tellides; Jordan S Pober; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

Review 2.  The link between IFN-gamma and allograft arteriopathy: is the answer NO?

Authors:  Richard N Mitchell; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

3.  Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Authors:  Birgit Fogal; Tai Yi; Chen Wang; Deepak A Rao; Amir Lebastchi; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

4.  CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.

Authors:  Gregor Warnecke; Gang Feng; Ryoichi Goto; Satish N Nadig; Ross Francis; Kathryn J Wood; Andrew Bushell
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

5.  Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells.

Authors:  A H Lebastchi; S F Khan; L Qin; W Li; J Zhou; N Hibino; T Yi; D A Rao; J S Pober; G Tellides
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

6.  Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.

Authors:  Tai Yi; Deepak A Rao; Paul C Y Tang; Yinong Wang; Lisa A Cuchara; Alfred L M Bothwell; Christopher M Colangelo; George Tellides; Jordan S Pober; Marc I Lorber
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

7.  B cells mediate chronic allograft rejection independently of antibody production.

Authors:  Qiang Zeng; Yue-Harn Ng; Tripti Singh; Ke Jiang; Khaleefathullah A Sheriff; Renee Ippolito; Salwa Zahalka; Qi Li; Parmjeet Randhawa; Rosemary A Hoffman; Balathiripurasundari Ramaswami; Frances E Lund; Geetha Chalasani
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

8.  A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.

Authors:  Jeffrey J Siracuse; Mark D Fisher; Cleide G da Silva; Clayton R Peterson; Eva Csizmadia; Herwig P Moll; Scott M Damrauer; Peter Studer; Lynn Y Choi; Sanah Essayagh; Elzbieta Kaczmarek; Elizabeth R Maccariello; Andy Lee; Soizic Daniel; Christiane Ferran
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

Review 9.  AIP1 in graft arteriosclerosis.

Authors:  Wang Min; Jordan S Pober
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

10.  Mouse models for graft arteriosclerosis.

Authors:  Lingfeng Qin; Luyang Yu; Wang Min
Journal:  J Vis Exp       Date:  2013-05-14       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.